Streetbeat News

Analyst Ratings

NBTB

Piper Sandler analyst Matthew Breese maintains an Overweight rating on NBT Bancorp (NASDAQ:NBTB) and raises the price target from $39 to $42.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 2:49 pm

NOW

Evercore ISI Group analyst Kirk Materne maintains an Overweight rating on ServiceNow (NYSE:NOW) and raises the price target from $550 to $650.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 2:49 pm

RKT

Piper Sandler analyst Kevin Barker has maintained a Neutral rating on Rocket Companies (NYSE:RKT) and raised the price target from $8 to $10.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 2:48 pm

SBOW

Northland Capital Markets analyst Donovan Schafer maintains an Outperform rating on SilverBow Resources (NYSE:SBOW) and raises the price target from $45 to $55.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 2:47 pm

ILMN

Piper Sandler analyst David Westenberg has maintained an Overweight rating on Illumina (NASDAQ:ILMN) but lowered the price target from $290 to $275.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 2:47 pm

OCX

Piper Sandler analyst David Westenberg has maintained a Neutral rating on OncoCyte (NASDAQ:OCX) and lowered the price target from $6 to $3.5.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 2:44 pm

CHS

DHI

MDC

MED

OXM

Benzinga Insights has identified five value stocks in the consumer cyclical sector that may be worth watching: D.R. Horton (DHI), Chico's FAS (CHS), M.D.C. Holdings (MDC), Medifast (MED), and Oxford Industries (OXM). The selection is based on the price-to-earnings (P/E) multiple, a common indicator of undervalued stocks. The companies have shown varying performance in terms of earnings per share and dividend yield.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 2:43 pm

TCRT

Laidlaw & Co. analyst Yale Jen has downgraded Alaunos Therapeutics (NASDAQ:TCRT) from Buy to Hold.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 2:43 pm

CCBG

Piper Sandler analyst Stephen Scouten maintains an Overweight rating on Capital City Bank Group (NASDAQ:CCBG) but lowers the price target from $42 to $38.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 15, 2023 | 2:43 pm

GRND

HUMA

NEXT

PHVS

PSFE

RSKD

SLGC

TAYD

Despite a general downturn in the US stock market, several stocks recorded gains. Pharvaris N.V. surged 19.4% after an upgrade from Morgan Stanley. Paysafe Limited jumped 18.9% after reporting Q2 FY23 revenue growth of 6% YoY, beating consensus. Taylor Devices, Inc. surged 18.6% following Q4 results. Grindr Inc. jumped 10.7% after reporting YoY increase in Q2 sales. SomaLogic, Inc. gained 10.6% after reporting better-than-expected Q2 results and issuing guidance. NextDecade Corporation climbed 10.3% after an upgrade from Stifel. Humacyte, Inc. gained 9.2% after a reiteration from Benchmark. Riskified Ltd. rose 8.2% after posting upbeat quarterly sales and boosting FY23 revenue guidance.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 2:43 pm